Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte
Cytonus Therapeutics is a biotech company combining AI-driven drug discovery with a Cargocyte, a synthetic biology approach towards drug-delivery. Cytonus is on a mission to treat immune related disorders with precision delivery and in vivo production of first in class therapeutics.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 1, 2021 | Grant | $300K | 1 | — | — | Detail |
| Mar 1, 2021 | Grant | $450K | 1 | — | — | Detail |
| Nov 1, 2020 | Grant | $400K | 1 | — | — | Detail |
| Oct 1, 2020 | Grant | — | 1 | — | — | Detail |
| Apr 1, 2020 | Grant | $325K | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |